Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

New understanding and treatments for hair loss are improving, but more research is needed.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Testosterone helps human pancreatic cells increase insulin release.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.